Meyahealth
HomeGeneticsGeneNOD2 gene
Back to Gene
NOD2 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

NOD2 gene

The NOD2 gene provides instructions for making a protein that helps the immune system recognize and respond to foreign invaders like bacteria.

Normal Function

The NOD2 gene (previously known as CARD15) provides instructions for making a protein that plays an important role in immune system function. The NOD2 protein is active in some types of immune system cells (including monocytes, macrophages, and dendritic cells), which help protect the body against foreign invaders such as bacteria and viruses. The protein is also active in several types of epithelial cells, including Paneth cells, which are found in the lining of the intestine. These cells help defend the intestinal wall against bacterial infection.

The NOD2 protein has several critical functions in defending the body against foreign invaders. The protein is involved in recognizing certain bacteria and stimulating the immune system to respond appropriately. When triggered by specific substances produced by bacteria, the NOD2 protein turns on (activates) a protein complex called nuclear factor-kappa-B. This protein complex regulates the activity of multiple genes, including genes that control immune responses and inflammatory reactions. An inflammatory reaction occurs when the immune system sends signaling molecules and white blood cells to a site of injury or disease to fight microbial invaders and facilitate tissue repair.

The NOD2 protein also appears to play a role in a process called autophagy, which cells use to surround and destroy bacteria, viruses, and other harmful substances. In addition to protecting cells from infection, autophagy is used to recycle worn-out cell parts and break down certain proteins when they are no longer needed. This process is also involved in the self-destruction of cells (apoptosis).

Health Conditions Related to Genetic Changes

Crohn's disease

Variations in the NOD2 gene have been associated with an increased risk of Crohn's disease, a complex disorder that causes inflammation of the digestive system. In particular, NOD2 gene changes are associated with a form of Crohn's disease that affects the lower part of the small intestine (the ileum) and the colon in populations of northern European descent. The three most common NOD2 variations are found in about 40 percent of all people with Crohn's disease. The most common of these, written as 3020insC or 1007fs, leads to the production of a NOD2 protein that is slightly shorter than normal. Other common variations change single amino acids in the NOD2 protein. It is unclear how these genetic changes increase the risk of developing Crohn's disease. Studies suggest that changes in the NOD2 gene prevent the protein from recognizing bacteria appropriately, allowing these microbes to grow unchecked and invade cells that line the intestine. An abnormal immune response to these bacteria may contribute to inflammation and the digestive problems characteristic of Crohn's disease.

Blau syndrome

At least 22 mutations in the NOD2 gene have been found to cause Blau syndrome, an inflammatory disorder that begins in childhood and primarily affects the skin, joints, and eyes. These mutations change single protein building blocks (amino acids) in the NOD2 protein. All of these mutations result in a version of the NOD2 protein that is overactive, which can trigger an abnormal inflammatory reaction and cause swelling and irritation. However, it is unclear how the abnormally active protein causes the specific pattern of inflammation affecting the skin, joints, and eyes that is characteristic of Blau syndrome.

NOD2 gene mutations can also cause early-onset sarcoidosis, a similar condition that some researchers consider to be a noninherited version of Blau syndrome.

Yao syndrome

Several variations in the NOD2 gene increase the risk of developing Yao syndrome, a disorder that causes episodes of fever and abnormal inflammation affecting many parts of the body. Most people with this condition have a variation in the NOD2 gene written as IVS8+158, which is located in a region of the gene called intron 8. Another relatively common NOD2 gene variation in people with Yao syndrome replaces the amino acid arginine with the amino acid tryptophan at position 702 in the NOD2 protein (written as Arg702Trp or R702W). These variations have also been identified in some people with Crohn's disease. About 20 percent of people with Yao syndrome have both the IVS8+158 and R702W variations, and some affected individuals have additional variations in the NOD2 gene.

The effects of having one, two, or more variations in the NOD2 gene is unclear, although studies suggest that these genetic changes may alter the activity (expression) of the NOD2 gene. It is unknown how these variations might contribute to abnormal inflammation in people with Yao syndrome. Researchers suspect that environmental factors such as infections may also play a role in triggering the disease in people with genetic variants that increase their risk.

Other disorders

Several studies have considered variations in the NOD2 gene as a possible risk factor for a condition called graft-versus-host disease (GVHD). GVHD can occur following certain cancer treatments, such as allogeneic stem cell transplantation. This procedure, which is typically used to treat cancers of the blood and immune system, replaces a patient's diseased blood-forming cells (a type of stem cell) with stem cells from a healthy donor. If the donor's stem cells (the graft) recognize the patient's body (the host) as foreign, they may attack organs and tissues such as the liver, digestive system, and skin.

A few studies have suggested that variations in the NOD2 gene influence the risk of developing severe complications of GVHD following an allogeneic stem cell transplant. The presence of NOD2 gene variations in both the stem cell donor and the recipient is associated with the greatest risk of a severe reaction. However, other research has found no relationship between NOD2 gene changes and the risk of developing GVHD.

Cancers

A few studies have suggested a possible association between changes in the NOD2 gene, particularly the common variation 3020insC, and the development of several types of cancer. Although some of these studies found an increased risk of cancer in people with a NOD2 gene variation, other research found no such association. It is unclear how changes in this gene might contribute to cancer risk.

Frequently Asked Questions

NOD2 mutations impair the protein's ability to detect certain bacteria in the gut, leading to a weakened immune response and increased inflammation in the intestinal lining. This dysregulation allows bacteria to trigger excessive inflammatory reactions, contributing to the tissue damage seen in Crohn's disease. However, NOD2 mutations are not sufficient to cause the disease on their own; they are considered susceptibility factors. Most people with these mutations do not develop Crohn's disease because other genetic and environmental factors, such as diet, smoking, and gut microbiome composition, also play critical roles in determining whether inflammation becomes chronic. What specific dietary or lifestyle changes are recommended for individuals with NOD2 mutations who are at higher risk for inflammatory bowel disease?::While there is no specific diet proven to prevent Crohn's disease in NOD2 carriers, general strategies to support gut health are recommended. These include maintaining a balanced diet rich in fiber and antioxidants, avoiding excessive processed foods, and limiting alcohol consumption. Smoking cessation is particularly important, as smoking significantly increases the risk of developing Crohn's disease and worsens its severity in those with genetic predispositions. Regular physical activity and stress management techniques may also help modulate immune responses and reduce the likelihood of inflammatory flare-ups. How does NOD2 testing influence the clinical management of patients already diagnosed with Crohn's disease?::NOD2 testing is not routinely used for diagnosis but can provide prognostic information. Patients with NOD2 mutations may have a higher risk of developing stricturing or penetrating disease, which may require more aggressive monitoring and earlier intervention. Knowing the genetic status can help clinicians tailor treatment plans, potentially favoring therapies that target specific inflammatory pathways. It may also inform decisions about surgical approaches and the likelihood of disease recurrence after resection, allowing for more personalized long-term management strategies. Are there any emerging treatments or research directions specifically targeting the NOD2 pathway in inflammatory bowel disease?::Research is ongoing to develop therapies that modulate the NOD2 pathway to restore proper immune recognition and reduce inflammation. Current studies are exploring small molecules that can enhance NOD2 signaling or inhibit downstream inflammatory cascades like NF-kappa-B activation. Additionally, probiotics and prebiotics are being investigated for their potential to alter the gut microbiome in ways that compensate for NOD2 dysfunction. While no NOD2-specific drugs are currently approved for clinical use, these approaches represent promising avenues for future personalized medicine in IBD treatment.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ